Bank of America’s Zymergen Inc. Common Stock ZY Stock Holding History

Bank of America’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-73,896	Closed	-$206K	–	8758
2022 Q3	$206K	Buy	73,896 +17,578	+31%	+$42.7K	﹤0.01%	5962
2022 Q2	$69K	Sell	56,318 -25,668	-31%	-$43K	﹤0.01%	6674
2022 Q1	$237K	Sell	81,986 -36,356	-31%	-$154K	﹤0.01%	6371
2021 Q4	$792K	Buy	118,342 +50,009	+73%	+$486K	﹤0.01%	5487
2021 Q3	$900K	Buy	68,333 +3,645	+6%	+$77.3K	﹤0.01%	5182
2021 Q2	$2.59M	Buy	+64,688	New	+$2.55M	﹤0.01%	4109

Bank of America's ZY Position: Q4 2022 in Review

Bank of America sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 73,896 shares — an estimated $206K sold.

Bank of America first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $2.59M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

Bank of America reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Bank of America sold 73,896 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $206K.
Bank of America first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Bank of America's Zymergen Inc. Common Stock position peaked at $2.59M in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.